Literature DB >> 32964857

COVID-19 in Chronic-Phase Chronic Myeloid Leukemia Patients: A Single-Center Survey from Turkey

Umut Yılmaz1, Aslıhan Pekmezci2, Yalçın Gül2, Ahmet Emre Eşkazan1.   

Abstract

Entities:  

Keywords:  COVID-19; Chronic myeloid leukemia; QTc prolongation; Drug-drug interaction; SARS-CoV-2; Tyrosine kinase inhibitor

Mesh：

Substances：

Year:  2020        PMID： 32964857      PMCID： PMC7927441          DOI： 10.4274/tjh.galenos.2020.2020.0472

Source DB:  PubMed          Journal:  Turk J Haematol        ISSN： 1300-7777            Impact factor:   1.831


× No keyword cloud information.
  7 in total

1.  Pleural and pericardial effusions in chronic myeloid leukemia patients receiving low-dose dasatinib therapy.

Authors:  Ahmet Emre Eskazan; Teoman Soysal; Seniz Ongoren; Emine Gulturk; Burhan Ferhanoglu; Yildiz Aydin
Journal:  Haematologica       Date:  2011-03       Impact factor: 9.941

2.  Chronic myeloid leukaemia and the use of tyrosine kinase inhibitors in the days of COVID-19 pandemic.

Authors:  Ahmet Emre Eşkazan
Journal:  Br J Clin Pharmacol       Date:  2020-05-20       Impact factor: 4.335

3.  Chronic myeloid leukemia management at the time of the COVID-19 pandemic in Italy. A campus CML survey.

Authors:  Massimo Breccia; Elisabetta Abruzzese; Monica Bocchia; Massimiliano Bonifacio; Fausto Castagnetti; Carmen Fava; Sara Galimberti; Antonella Gozzini; Gabriele Gugliotta; Alessandra Iurlo; Roberto Latagliata; Luigiana Luciano; Patrizia Pregno; Giovanna Rege-Cambrin; Gianantonio Rosti; Fabio Stagno; Mario Tiribelli; Robin Foà; Giuseppe Saglio
Journal:  Leukemia       Date:  2020-06-18       Impact factor: 11.528

4.  COVID-19 in persons with chronic myeloid leukaemia.

Authors:  Weiming Li; Danyu Wang; Jingming Guo; Guolin Yuan; Zhuangzhi Yang; Robert Peter Gale; Yong You; Zhichao Chen; Shiming Chen; Chucheng Wan; Xiaojian Zhu; Wei Chang; Lingshuang Sheng; Hui Cheng; Youshan Zhang; Qing Li; Jun Qin; Li Meng; Qian Jiang
Journal:  Leukemia       Date:  2020-05-18       Impact factor: 11.528

5.  Prevalence of COVID-19 diagnosis in Dutch CML patients during the 2020 SARS-CoV2 pandemic. A prospective cohort study.

Authors:  Geneviève I C G Ector; Elisabeth G W Huijskens; Nicole M A Blijlevens; Peter E Westerweel
Journal:  Leukemia       Date:  2020-07-08       Impact factor: 11.528

6.  SARS-CoV-2 (COVID-19) and Chronic Myeloid Leukemia (CML): a Case Report and Review of ABL Kinase Involvement in Viral Infection.

Authors:  Elisabetta Abruzzese; Luigiana Luciano; Francesco D'Agostino; Malgorzata Monika Trawinska; Fabrizio Pane; Paolo De Fabritiis
Journal:  Mediterr J Hematol Infect Dis       Date:  2020-05-01       Impact factor: 2.576

Review 7.  European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia.

Authors:  A Hochhaus; M Baccarani; R T Silver; C Schiffer; J F Apperley; F Cervantes; R E Clark; J E Cortes; M W Deininger; F Guilhot; H Hjorth-Hansen; T P Hughes; J J W M Janssen; H M Kantarjian; D W Kim; R A Larson; J H Lipton; F X Mahon; J Mayer; F Nicolini; D Niederwieser; F Pane; J P Radich; D Rea; J Richter; G Rosti; P Rousselot; G Saglio; S Saußele; S Soverini; J L Steegmann; A Turkina; A Zaritskey; R Hehlmann
Journal:  Leukemia       Date:  2020-03-03       Impact factor: 11.528
  7 in total
  2 in total

1.  COVID-19 pneumonia concurrent with newly diagnosed chronic myelogenous leukemia.

Authors:  Chul Soo Kim; Jeong Yeon Kim; Dae Ro Choi
Journal:  Blood Res       Date:  2022-03-31

2.  Co-occurrence of CML Blast Crisis and Severe COVID 19 Infection: A Case Report.

Authors:  Misbahuddin Khaja; Vibha Hayagreev; Asim Haider; Diana Ronderos; Ayesha Siddiqa; Valentina Moirangthem
Journal:  Cureus       Date:  2022-07-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.